We then selected six genes (HNRNPH1, DSC2, FBXO9, MANEA, OR51E1, PRR15L) for validation by qRT-PCR that were over-expressed in prostate cancer across all datasets and showed high fold changes in our microarray (Supplementary Figure 1B). The gene discussed is FBXO9; the disease is prostate cancer.